Back

Sex-related differences in left ventricular geometry patterns in patients with arterial hypertension

30 August 2024 (15:00 - 15:50)
Organised by: Logo
Congress Presentation Part of: Hypertension target organ damage Target Organ Damage/Left Ventricular Hypertrophy ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Associate Professor Maria-Angela Losi

University of Naples Federico II, Naples (Italy)

8 More presentations in this session

Presentation thumbnail
Orthostatic blood pressure changes and incident atrial fibrillation in patients with hypertension: Insights from the SPRINT trial
Doctor J. Wang (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Diagnostic and prognostic value of ECG-predicted hypertension mediated left ventricular hypertrophy using machine learning
Doctor H. Naderi (London, GB)
Abstract Slides Video
Presentation thumbnail
Carotid-Femoral pulse wave velocity progression in hypertensive patients is associated with subsequent cardiovascular outcomes
Doctor A. Maloberti (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Cardiac magnetic resonance (CMR) height-based allometric scaling in Southeast Asians; implications in the diagnosis and prognosis of left ventricular hypertrophy (LVH): the REMODEL study
Mr C. Lee (Dundee, GB)
Abstract Slides Video
Presentation thumbnail
Relationship between renin, aldosterone, aldosterone-to-renin ratio and left ventricular mass index in young adults
Doctor R. Ananda (Melbourne, AU)
Abstract Slides Video

Access the full session

Session thumbnail
Hypertension target organ damage

The Event

Event poster

ESC Congress 2024

30 August 2024 15:00 CET
You may be interested in
thumbnail
Congress Presentation
Predisposition to hypertensive heart disease: are there sex differences?
thumbnail
Congress Presentation
Sex differences in left ventricular dilatation in patients with significant aortic regurgitation: prognostic implications
thumbnail
Congress Presentation
Gender-related differences in clinical characteristics of patients with hypertrophic cardiomyopathy in our city

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources